Skip to main content
. 2021 Mar 5;14:1756286421999631. doi: 10.1177/1756286421999631

Table 2.

Overview of first- and second-line drugs used in the whole cohort.

n %
First-line drugs
 Intravenous immunoglobulins 153 85
 Steroids 133 74
 Plasma exchange 22 12
 Subcutaneous immunoglobulins 15 8
Second-line drugs
 Azathioprine 66 36
 Mycophenolate mofetil 38 21
 Steroids (orally) 30 17
 Ciclosporin A 24 13
 Methotrexate 6 3
Therapy regimens of 181 patients (90.5%) were available.